Koral Shah, Fellow at City of Hope, shared a post on X:
“HER2 in UC
Vadim Koshkin et al evaluated 2,024 advanced UC tumors for HER2 by IHC and ERBB2 amplification! High HER2 expression (IHC ≥1+) was common—even w/o amplification.
We wrote an editorial published in JCO Precision Oncology to unpack the clinical relevance.”
Title: Human Epidermal Growth Factor Receptor 2 Testing in Urothelial Carcinoma
Authors: Koral U. Shah, Abhishek Tripathi
Read the Full Article.
